Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices

Stopped Recruitment was severely affected due to COVID, so study was stopped prematurely.

Conditions

• Esophageal Varices
• Liver Cirrhoses
• Bleeding Esophageal Varices
• Upper Gastrointestinal Bleeding

Interventions

• DRUG: Octreotide

Sponsor

Medical University of South Carolina

Collaborators

• [object Object]
• [object Object]
• [object Object]